SEC Form 4 · accession 0001739481-18-000011
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Doucot
Officer — Vice President Sales & Mktg
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 3:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right-to-Buy)F1 | $21.04 | May 3, 2018 | A | 18,000 | A | — | May 3, 2028 | Common Stock, $.005 Par Value | 18,000 | 18,000 | D |
Explanation of responses
- F1The option becomes exercisable with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafer, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date.